Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease-Reference-Cited by-同舟云学术

Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease

Published:2023-12-29 Issue: Volume: Page:
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Massa Federico^ORCID,Martinuzzo Caterina,Gómez de San José Nerea,Pelagotti Virginia,Kreshpa Wendy,Abu-Rumeileh Samir,Barba Lorenzo,Mattioli Pietro,Orso Beatrice,Brugnolo Andrea,Girtler Nicola,Vigo Tiziana,Arnaldi Dario,Serrati Carlo,Uccelli Antonio,Morbelli Silvia,Chincarini Andrea,Otto Markus,Pardini Matteo

Funder

Ministero dell'Università e della Ricerca

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-023-12154-7.pdf

Reference39 articles.

1. Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM (2020) Synaptic Health Endpoints Working Group. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease. Alzheimers Res Ther 12(1):21. https://doi.org/10.1186/s13195-020-00588-4. PMID: 32122400; PMCID: PMC7053087

2. Sperling RA, Aisen PS, Beckett LA et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia 7:280–292. https://doi.org/10.1016/j.jalz.2011.03.003

3. Lleó A, Núñez-Llaves R, Alcolea D et al (2019) Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer’s disease cerebrospinal fluid*. Mol Cell Proteomics 18:546–560. https://doi.org/10.1074/mcp.RA118.001290

4. Selkoe DJ (1979) (2002) Alzheimer’s disease is a synaptic failure. Science 298:789–791

5. Camporesi E, Nilsson J, Brinkmalm A, Becker B, Ashton NJ, Blennow K, Zetterberg H (2020) Fluid Biomarkers for Synaptic Dysfunction and Loss. Biomark Insights 15:1177271920950319. https://doi.org/10.1177/1177271920950319. PMID: 32913390; PMCID: PMC7444114

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases;Journal of the Neurological Sciences;2024-07